Galindo RJ, et al. Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen. Diabetes Care. 2020; 43:2730-2735. doi : 10.2337/dc19-2073 Singh LG, et al. Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose […]
Lundsgaard AM et al. Decreased Incidence of Type 1 Diabetes in Young Finnish Ch Small Amounts of Dietary Medium-Chain Fatty Acids Protect Against Insulin Resistance During Caloric Excess in Humans. Diabetes 2020; 29;db200582. doi : 10.2337/db20-0582 Depuis une dizaine d’années, les acides gras (AG) saturés sont considérés comme délétères pour la sensibilité à l’insuline […]
Clément K, et al. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol. 2020; 12:960-970. doi : 10.1016/S2213-8587(20)30364-8 L’obésité est une maladie complexe, multifactorielle, associée à une augmentation de la morbi-mortalité. De rares mutations dans […]
Cognitive function following diabetic ketoacidosis in children with new-onset or previously diagnosed type 1 diabetes. Diabetes Care 2020; 43: 2768-2775. doi : 10.2337/dc20-0187 L’acidocétose diabétique (ACD) est une complication fréquente du diabète de type 1 (DT1). Elle est présente dans 25 à 40% des cas à la découverte d’un DT1. Des lésions cérébrales ont […]
Zaccardi F, et al. Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study. Diabetologia. 2020;63:2129-2139. doi : 10.1007/s00125-020-05223-3 Depuis les résultats décevants des grandes études de contrôle glycémique de 2008 en particulier ceux d’ACCORD, les hypoglycémies sont sur la sellette. Elles ont en […]
Parviainen A et al. Decreased Incidence of Type 1 Diabetes in Young Finnish Children. Diabetes Care 2020; Sept dc200604. doi : 10.1056/NEJMoa2003697 Le diabète de type 1 (DT1) est l’une des maladies chroniques de l’enfance les plus communes, particulièrement en Finlande, qui enregistre la plus forte incidence au monde [1]. L’incidence mondiale du DT1 […]
Feig DS et al. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebocontrolled trial. Lancet Diabetes Endocrinol 2020 Oct; 8: 833-844. doi : 10.1016/S2213-8587(20)30310-7 La prévalence du diabète de type 2 (DT2) chez les femmes enceintes a plus que doublé sur les vingt dernières années [1] du fait […]
Samaras et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study. Diabetes Care 2020; dc200892. doi : 10.2337/dc20-0892 Le diabète de type 2 (DT2) est associé à une augmentation du risque de déclin cognitif et de démence. […]
Larsen MD, et al. Live-born children after assisted reproduction in women with type 1 diabetes and type 2 diabetes: a nationwide cohort study. Diabetologia. 2020 ; 63: 1736-1744. doi : 10.1007/s00125-020-05193-6 Le diabète de type 1 (DT1) et de type 2 (DT2) sont parmi les maladies chroniques les plus fréquentes chez les femmes en âge […]
Yoshino M et al. Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes. The New England Journal of Medicine 2020; 383:721-732. doi : 10.1056/NEJMoa2003697 Les essais cliniques contrôlés randomisés ont montré la supériorité de la chirurgie bariatrique sur le traitement médical dans le diabète de type 2 (DT2) [1, 2]. De plus, […]
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
